1. The multiplication of analogs, the best strategy for rapid extension of the Oncostatic Arsenal

   • G. Mathé
   • C. Jasmin

   Editorial Pages: 203 - 205

2. Retinoids and cancer

   • W. Bollag

   General Review Pages: 207 - 215

3. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin

   • M. Hayat
   • C. Bourut
   • G. Mathé

   Original Articles Pages: 217 - 221

4. Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-α-tocopheryl acetate or coenzyme Q₁₀ in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q₁₀)

   • Naoki Yamanaka
   • Taketoshi Kato
   • Kazuo Ota

   Original Articles Pages: 223 - 227

5. 2′-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside

   • V. M. Buchman
   • N. I. Belyanchikova
   • G. J. Svet-Moldavsky

   Original Articles Pages: 229 - 234

6. Enhancement of methotrexate absorption by subdivision of dose

   • W. H. Steele
   • J. F. B. Stuart
   • J. G. McVie

   Original Articles Pages: 235 - 237

7. Bioavailability of methotrexate: Implications for clinical use

   • J. F. B. Stuart
   • K. C. Claman
   • J. G. McVie

   Original Articles Pages: 239 - 241

8. Human pharmacolinetics of the daunorubicin-DNA complex

   • R. Hulhoven
   • G. Sokal
   • C. Harvengt

   Original Articles Pages: 243 - 247

9. Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals

   • F. Villani
   • G. Beretta
   • A. Guindani

   Original Articles Pages: 249 - 251

10. The disposition of cyclophosphamide in a group of myeloma patients

    • Vivien Bramwell
    • R. T. Calvert
    • D. Crowther

    Original Articles Pages: 253 - 259

11. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors

    • Franca Formelli
    • Anna Maria Casazza
    • Carmen Pollini

    Original Articles Pages: 261 - 269